301 related articles for article (PubMed ID: 11517335)
1. Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease.
Monsonego A; Maron R; Zota V; Selkoe DJ; Weiner HL
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10273-8. PubMed ID: 11517335
[TBL] [Abstract][Full Text] [Related]
2. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
3. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
[TBL] [Abstract][Full Text] [Related]
4. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic active immunization with a novel epitope vaccine improves cognitive ability by decreasing amyloid plaques and neuroinflammation in APP/PS1 transgenic mice.
Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
Neurosci Res; 2017 Jun; 119():7-14. PubMed ID: 28111220
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice.
Petrushina I; Ghochikyan A; Mktrichyan M; Mamikonyan G; Movsesyan N; Davtyan H; Patel A; Head E; Cribbs DH; Agadjanyan MG
J Neurosci; 2007 Nov; 27(46):12721-31. PubMed ID: 18003852
[TBL] [Abstract][Full Text] [Related]
8. Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.
Maier M; Seabrook TJ; Lazo ND; Jiang L; Das P; Janus C; Lemere CA
J Neurosci; 2006 May; 26(18):4717-28. PubMed ID: 16672644
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development.
Nath A; Hall E; Tuzova M; Dobbs M; Jons M; Anderson C; Woodward J; Guo Z; Fu W; Kryscio R; Wekstein D; Smith C; Markesbery WR; Mattson MP
Neuromolecular Med; 2003; 3(1):29-39. PubMed ID: 12665674
[TBL] [Abstract][Full Text] [Related]
10. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
11. Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice.
Balakrishnan K; Rijal Upadhaya A; Steinmetz J; Reichwald J; Abramowski D; Fändrich M; Kumar S; Yamaguchi H; Walter J; Staufenbiel M; Thal DR
Acta Neuropathol Commun; 2015 Jul; 3():41. PubMed ID: 26141728
[TBL] [Abstract][Full Text] [Related]
12. Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 mice.
Biscaro B; Lindvall O; Hock C; Ekdahl CT; Nitsch RM
J Neurosci; 2009 Nov; 29(45):14108-19. PubMed ID: 19906959
[TBL] [Abstract][Full Text] [Related]
13. Active Aβ vaccination fails to enhance amyloid clearance in a mouse model of Alzheimer's disease with Aβ42-driven pathology.
Nemirovsky A; Shapiro J; Baron R; Kompaniets A; Monsonego A
J Neuroimmunol; 2012 Jun; 247(1-2):95-9. PubMed ID: 22498096
[TBL] [Abstract][Full Text] [Related]
14. Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice.
Petrushina I; Ghochikyan A; Mkrtichyan M; Mamikonyan G; Movsesyan N; Ajdari R; Vasilevko V; Karapetyan A; Lees A; Agadjanyan MG; Cribbs DH
J Neuroinflammation; 2008 Sep; 5():42. PubMed ID: 18823564
[TBL] [Abstract][Full Text] [Related]
15. An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.
Sigurdsson EM; Knudsen E; Asuni A; Fitzer-Attas C; Sage D; Quartermain D; Goni F; Frangione B; Wisniewski T
J Neurosci; 2004 Jul; 24(28):6277-82. PubMed ID: 15254082
[TBL] [Abstract][Full Text] [Related]
16. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.
Dickstein DL; Biron KE; Ujiie M; Pfeifer CG; Jeffries AR; Jefferies WA
FASEB J; 2006 Mar; 20(3):426-33. PubMed ID: 16507760
[TBL] [Abstract][Full Text] [Related]
17. Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice.
Bard F; Fox M; Friedrich S; Seubert P; Schenk D; Kinney GG; Yednock T
Exp Neurol; 2012 Nov; 238(1):38-43. PubMed ID: 22892246
[TBL] [Abstract][Full Text] [Related]
18. CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation.
Obregon D; Hou H; Bai Y; Nikolic WV; Mori T; Luo D; Zeng J; Ehrhart J; Fernandez F; Morgan D; Giunta B; Town T; Tan J
Neurobiol Dis; 2008 Feb; 29(2):336-53. PubMed ID: 18055209
[TBL] [Abstract][Full Text] [Related]
19. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of β1 antibody in brain neurons impairs age-dependent amyloid deposition in APP23 mice.
Paganetti P; Reichwald J; Bleckmann D; Abramowski D; Ammaturo D; Barske C; Danner S; Molinari M; Müller M; Papin S; Rabe S; Schmid P; Staufenbiel M
Neurobiol Aging; 2013 Dec; 34(12):2866-78. PubMed ID: 23870837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
